Adverum Biotechnologies News

Adverum Biotechnologies | DEFA14A: Others

04:35

Adverum Biotechnologies | DEF 14A: Definitive information statements

04:31

Adverum Biotechnologies | S-3: Registration statement for specified transactions by certain issuers

Mar 22 05:27

Adverum Biotechnologies | 8-K: Current report

Mar 21 04:19

Adverum Biotechnologies | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 19 05:01

Adverum Biotechnologies | 8-K: Adverum Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Pipeline Highlights and Corporate Updates

Mar 19 04:12

Adverum Biotechnologies | S-3: Registration statement for specified transactions by certain issuers

Mar 5 05:41

Adverum Biotechnologies | 8-K: Current report

Feb 8 21:50

Adverum Biotechnologies | 8-K: Current report

Feb 7 05:48

Adverum Biotechnologies | 8-K: Current report

Feb 6 06:10

Adverum Biotechnologies | 8-K: Current report

Dec 9, 2023 05:11

Adverum Biotechnologies | 8-K/A: Current report (Amendment)

Dec 5, 2023 05:09

Adverum Biotechnologies | 8-K: Adverum Biotechnologies Reports Third Quarter 2023 Financial Results and Pipeline Highlights

Nov 10, 2023 05:07

Adverum Biotechnologies | 8-K: Current report

Nov 7, 2023 05:10

Adverum Biotechnologies | 8-K: Adverum Biotechnologies Completes Enrollment of Phase 2 LUNA Trial in Wet AMD and Reports Second Quarter 2023 Financial Results

Aug 11, 2023 04:09

Adverum Biotechnologies | 8-K: Current report

Aug 5, 2023 04:18

Adverum Biotechnologies | 8-K: Current report

Jun 15, 2023 04:01

Adverum Biotechnologies | 8-K: Current report

Jun 10, 2023 04:29

Adverum Biotechnologies | 8-K: Current report

May 25, 2023 18:29

Adverum Biotechnologies | 8-K: Current report

May 20, 2023 04:07